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Functional Interplay between Mitochondrial
and Proteasome Activity in Skin Aging
Rafał Kozieł1,5, Ruth Greussing1,5, Andrea B. Maier2,3, Lieve Declercq4 and Pidder Jansen-Du¨rr1
According to the mitochondrial theory of aging, reactive oxygen species (ROS) derived primarily from
mitochondria cause cumulative oxidative damage to various cellular molecules and thereby contribute to the
aging process. On the other hand, a pivotal role of the proteasome, as a main proteolytic system implicated in
the degradation of oxidized proteins during aging, is suggested. In this study, we analyzed mitochondrial
function in dermal fibroblasts derived from biopsies obtained from healthy young, middle-aged, and old
donors. We also determined proteasome activity in these cells, using a degron–destabilized green fluorescent
protein (GFP)-based reporter protein. We found a significant decrease in mitochondrial membrane potential in
samples from aged donors, accompanied by a significant increase in ROS levels. Respiratory activity was not
significantly altered with donor age, probably reflecting genetic variation. Proteasome activity was significantly
decreased in fibroblasts from middle-aged donors compared with young donors; fibroblasts derived from the
oldest donors displayed a high heterogeneity in this assay. We also found intraindividual coregulation of
mitochondrial and proteasomal activities in all human fibroblast strains tested, suggesting that both systems are
interdependent. Accordingly, pharmacological inhibition of the proteasome led to decreased mitochondrial
function, whereas inhibition of mitochondrial function in turn reduced proteasome activity.
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INTRODUCTION
The mitochondrial theory of aging (Miquel, 1991) proposes
that reactive oxygen species (ROS), generated from oxidative
phosphorylation (OXPHOS), induce mutations in mtDNA,
which in turn leads to OXPHOS dysfunction and hence
further ROS generation (Balaban et al., 2005). Elevated ROS
levels can potentially cause cumulative damage to various
cellular molecules, like proteins, lipids, and nucleic acids,
and contribute to a decrease in physiological functions with
age. This mechanism was proposed as a main contributor to
the aging process (Berlett and Stadtman, 1997; Beckman and
Ames, 1998). Accordingly, a decrease in superoxide level by
the overexpression of catalase in mitochondria was shown to
prolong the lifespan of mice (Schriner et al., 2005).
However, other studies using transgenic and knockout
mouse models do not support the theory as originally stated.
In particular, recent studies using mouse models with altered
expression of mitochondrial antioxidant enzymes do not
support a clear role for mitochondrial oxidative stress or a
vicious cycle of oxidative damage for lifespan determination
in mice (reviewed by Jang and Remmen, 2009). Mutant mice
models that have been genetically manipulated to increase
mitochondrial mutations display a variety of aging pheno-
types (Trifunovic et al., 2004). The fact that such mice did not
display any signs of increased oxidative stress (Trifunovic
et al., 2005) is not easily reconciled with the mitochon-
drial theory of aging, although one may argue that the
ratio between ROS production and oxygen consumption
is increased in cells carrying mtDNA point mutations
(Trifunovic et al., 2005). Furthermore, recent studies demon-
strated that mice heterozygous for CLK1 (CDC-like kinase 1),
a mitochondrial enzyme necessary for ubiquinone biosynth-
esis, are long-lived despite massive mitochondrial dysfunc-
tion starting early in life (Lapointe and Hekimi, 2008).
Together, these findings suggest that the mitochondrial
oxidative stress theory of aging may need to be reformulated
(for recent review, see Lapointe and Hekimi, 2010).
Many data obtained on human tissues tend to support the
mitochondrial theory of aging (reviewed by Balaban et al.,
2005). Thus, excess production of ROS increases oxidative
damage to mtDNA (Hayakawa et al., 1992). Accordingly, the
ORIGINAL ARTICLE
594 Journal of Investigative Dermatology (2011), Volume 131 & 2011 The Society for Investigative Dermatology
Received 25 June 2010; revised 12 October 2010; accepted 5 November
2010; published online 30 December 2010
1Institute for Biomedical Aging Research (IBA), Austrian Academy of Sciences,
Innsbruck, Austria; 2Department of Gerontology and Geriatrics, Leiden
University Medical Center, Leiden, The Netherlands; 3Netherlands Consortium
for Healthy Aging, Leiden University Medical Center, Leiden, The Netherlands
and 4Estee Lauder Research Center, Oevel, Belgium
Correspondence: Pidder Jansen-Duerr, Institute for Biomedical Aging
Research (IBA), Austrian Academy of Sciences, Rennweg 10, 6020 Innsbruck,
Austria. E-mail: p.jansen-duerr@oeaw.ac.at
5These two authors contributed equally to this work.
Abbreviations: ATP, adenosine-5’-triphosphate; DHE, dihydroethidium;
FCCP, carbonyl cyanide p-trifluoromethoxyphenylhydrazone; GFP, green
fluorescent protein; HFF-2, human foreskin fibroblasts; LLnL, N-acetyl-L-
leucyl-L-leucyl-L-norleucinal; mt DNA, mitochondrial DNA; OXPHOS,
oxidative phosphorylation; PBS, phosphate-buffered saline; PDL, population
doubling level; ROS, reactive oxygen species
accumulation of point mutations (Hayakawa et al., 1991) and
large-scale deletions (Cortopassi and Arnheim, 1990) of mtDNA
has been observed in samples from aged donors (for recent
review, see Wiesner et al., 2006; Pang et al., 2008).
Mitochondrial respiratory activity was reported to decrease
with age in several human tissues, such as the liver (Yen et al.,
1989) and skeletal muscle (Trounce et al., 1989; Conley et al.,
2000). Based on in vivo studies with 13C/31P nuclear magnetic
resonance spectroscopy, a significant reduction in mitochon-
drial oxidative and phosphorylation activity was reported for
human skeletal muscle (Petersen et al., 2003). On the other
hand, a growing body of evidence indicates full preservation of
mitochondrial function in samples obtained from elderly
donors. Thus, no significant decline of mitochondrial function
has been observed on mitochondria isolated from aged human
skeletal muscles (Rasmussen et al., 2003); similarly, aged
human skeletal muscles were shown to contain fully functional
mitochondria and relatively low ROS levels (Hutter et al.,
2007). It was shown that cells with deficient and intact
mitochondria can coexist within the same tissue, e.g., in human
colon crypts, and the proportion of crypts with functionally
deficient mitochondria was found to increase with age,
probably because of clonal expansion (Greaves et al., 2006).
Such age-associated mitochondrial DNA mutations were shown
to attenuate proliferation and increase apoptosis, leading to
decreased cell proliferation (Nooteboom et al., 2010). Others
reported a significant decrease in mitochondrial protein
synthesis rate in human skin fibroblasts obtained from elderly
donors (Greco et al., 2003), accompanied by reduced efficiency
of the OXPHOS system. In summary, the extent of age-related
mitochondrial dysfunction may vary between different tissues,
and its role for human aging remains to be fully understood.
One of the most common symptoms of aging at the
molecular level is the accumulation of altered proteins within
cells (Rosenberger, 1991; Rattan et al., 1992). The accumula-
tion of oxidatively modified proteins may be because of
increased protein damage and/or decreased elimination of
oxidized proteins. As the proteasome is the main intracellular
proteolytic pathway implicated in the degradation of
oxidized proteins (Coux et al., 1996; Davies, 2001), its role
during aging has become a popular target of research (for
review, see Breusing and Grune, 2008). In most cases,
proteasome activity was reported to decrease with aging.
Thus, proteasome activity was decreased in extracts obtained
from aged rat heart (Bulteau et al., 2002), muscle (Husom
et al., 2004), retina (Louie et al., 2002), lung, kidney, and
spinal cord (Keller et al., 2000), as well as mouse skeletal
muscle (Strucksberg et al., 2009). However, there seem to be
exceptions. For example, the three best-characterized pro-
teasomal peptidase activities, chymotrypsin-like, trypsin-like,
and peptidylglutamyl peptide-hydrolyzing activities, have
been reported to either increase, not change, or decrease
with age, both in rat liver and mouse muscle (Shibatani et al.,
1996; Conconi and Friguet, 1997; Anselmi et al., 1998;
Ferrington et al., 2005). Most of the studies mentioned above
used cellular extracts to determine the abundance and
modification of proteasome subunits, as well as the catalytic
activity of proteasomal peptidase activities. Interestingly, a
recent investigation of in vivo proteasome activity in
transgenic ubiquitin–proteasome system reporter mice indi-
cated that aging alone did not significantly impair proteasomal
function in this model system (Cook et al., 2009), raising the
possibility that changes of proteasome activity detected by
in vitro assays do not necessarily fully recapitulate proteasome
activity in the cellular and organismal environment.
Concerning proteasome function in human aging, most
studies used replicative senescence as a model system. A
senescence-associated decline in proteasome activity was
found in extracts from keratinocytes (Petropoulos et al., 2000)
and fetal lung fibroblasts (Sitte et al., 2000; Chondrogianni
et al., 2003; Torres et al., 2003, 2006). In addition, protea-
some activity was reported to decline with donor age in
extracts prepared from human skin (Bulteau et al., 2000;
Hwang et al., 2007), human trabecular meshwork cells
(Caballero et al., 2004), and human peripheral blood
lymphocytes (Ponnappan, 2002; Carrard et al., 2003).
Although many studies have been performed to investigate
the role of mitochondria and proteasome activity in aging,
a possible interplay of these two organelles during aging
has not been systematically studied with human samples,
which was the major goal of this study.
RESULTS
Changes of mitochondrial function in dermal fibroblasts
from young and elderly donors
To assess the influence of donor age on mitochondrial
functionality, we tested human dermal fibroblasts obtained from
three age groups, referred to as young (23–29 years old), middle
aged (60±8 years old), and old (90 years old). The strains,
obtained from the Leiden 85-plus study and the Leiden
Longevity Study, were cultivated under standardized conditions
and analyzed at early passage after isolation for mitochondrial
activity, using high-resolution respirometry and flow cytometric
determination of the mitochondrial membrane potential (Dcm).
When the data were grouped according to donor age, no
significant correlation of mitochondrial respiratory activity or the
rate of respiration coupled with OXPHOS (Table 1) with donor
age was obtained (P40.21 and P40.53, respectively). Mea-
surement of citrate synthase activity, frequently used as a marker
for mitochondrial mass (Kuznetsov et al., 2002), was signifi-
cantly lower in biopsies from young donors, compared with
both middle-aged and old donors, suggesting that mitochondrial
mass increases with donor age (Figure 1a). Flow cytometric
determination of the percentage of cells with high Dcm (for
details, see Supplementary Materials and Methods online)
revealed a significant progressive decrease in Dcm with donor
age (Po0.05 for middle aged and Po0.001 for old; Figure 1b),
and this was accompanied by a linear increase in intracellular
ROS generation with donor age (Po0.001; Figure 1c). Taken
together, the data indicate a progressive decrease in Dcm with
donor age together with increased ROS generation.
Decreased proteasome activity in fibroblasts from elderly
donors
To be able to monitor proteasome activity in living primary
cells, complementary DNA constructs coding for a green
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fluorescent protein (GFP)–degron fusion protein (GFP–degron,
unstable) and a variant carrying a frameshift mutation
(GFP–degronFS, stable; see Bence et al., 2001) were inserted
in lentiviral expression vectors. This, to our knowledge
previously unreported, technique is preferred over traditional
transfection technique because it guarantees a very high
transfection efficiency independent of the cell type or the age
of the donor. The difference between fluorescence displayed
by the GFP–degronFS (stable) protein and the destabilized
protein in the absence and presence of proteasome inhibitor
can be used to estimate proteasome activity in each particular
cell strain. The functionality of the GFP–degron system and its
regulation by the proteasome was verified in human foreskin
fibroblasts (HFF-2) cells by epifluorescence microscopy to
detect GFP (Figure 2a) and by flow cytometry (Figure 2b).
Experiments were performed both in the absence and the
presence of proteasome inhibitor N-Acetyl-L-leucyl-L-leucyl-
L-norleucinal (LLnL). Inhibition of proteasome activity in
GFP–degron-expressing cells increased the proportion of
positive cells from 6 to 63% (Figure 2b), whereas LLnL
treatment of GFP–degronFS-expressing cells only marginally
increased the number of positive cells (Figure 2b). The data
obtained demonstrate that this system is useful to determine
proteasome activity in living cells, including normal human
diploid fibroblasts.
Dermal fibroblasts obtained from donors of young,
middle-aged, and old subjects were infected by lentiviral
vectors expressing GFP–degron fusion proteins, and culti-
vated to the same passage number before they were analyzed
by flow cytometry. In these experiments, we observed
decreased stability of the GFP–degron fusion protein in
fibroblasts from young donors (11.2±0.88% GFP-positive
cells) compared with the group of middle-aged donors
(20.4±2.27% GFP-positive cells, P¼ 0.003), suggesting a
decrease in proteasome activity with aging (Figure 2c). No
further decrease of proteasome activity was evident when
fibroblasts from the old donors, 90 years of age, were
analyzed (21.7±13.4% GFP-positive cells, P¼0.09 with
respect to young subjects); the interindividual variation was
highest in the old group (Figure 2c). In control experiments,
cells were infected with lentiviral vectors coding for
GFP–degronFS fusion proteins, which revealed 40–60%
GFP-positive cells irrespective of donor age (data not shown).
Coregulation of mitochondrial and proteasome activity in
fibroblasts from subsequent biopsies taken from the same donor
Fibroblast cultures isolated from a single donor at different
time points were obtained from the Coriell Institute. As cells
were obtained at different passage numbers, an influence of
in vitro passaging on the cellular phenotype could be
expected and was controlled for. The following fibroblast
strains obtained from one subject were used for analysis:
strain A (biopsy taken at age 46 years, frozen at 9 population
doubling level (PDL)), strain B (biopsy taken at age 36 years,
frozen at 14 PDL), and strain C (biopsy taken at age 29 years,
frozen at 18 PDL). Cells were taken in culture and
mitochondrial function was analyzed by high-resolution
respirometry and by the determination of the Dcm. Mito-
chondrial mass, determined by measurement of citrate
synthase activity, was lowest in sample A, followed by
samples B and C (Supplementary Figure S1 online, panel A).
We found significant differences in mitochondrial respiratory
activity between the various fibroblast cultures. Interestingly,
mitochondrial activity was highest in strain A (Table 2).
Table 1. Respiration of human skin fibroblasts in various states of mitochondrial respiratory control
Mean (SE)1
Young Middle aged Old D(SE)2 P-value2 D(SE)3 P-value3
N4 3 3 3
Respiration/CS
Routine 1,655 (64) 1,549 (104) 1,607 (102) +107 (116) 0.39 +49 (115) 0.69
Oligomycin 415 (42) 369 (39) 449 (44) +47 (68) 0.42 34 (59.6) 0.58
Uncoupled 5,156 (189) 5,085 (329) 4,692 (301) +71 (331) 0.85 +463 (327) 0.21
Rotenone 174 (33) 164 (37) 197 (36) +10 (57) 0.84 24 (47) 0.64
Antimycin A 127 (35) 129 (29) 143 (19) 2 (56) 0.96 16 (39) 0.69
(R-j4o)/CS
5 1,241 (63) 1,180 (92) 1,158 (112) +60 (115) 0.60 +83 (120) 0.53
Abbreviations: CS, citrate synthase; R, routine respiration.
1Skin fibroblasts from nine different donors in the indicated age groups (young: 20 years, middle aged: 60 years, and old: 90 years) were obtained from
subjects of the Leiden 85-plus Study and the Leiden Longevity Study at the same passage level. Respiration was measured by high-resolution respirometry.
Respiratory parameters were normalized by CS activity expressed in international units (IU) (pmol of O2 s
1 IU1). Data represent the means±SE for three
independent experiments.
2Difference between young and middle-aged subjects.
3Difference between young and old subjects.
4N is the number of subjects.
5(R-j4o)/CS is the rate of respiration coupled with ATP production (pmol of O2 s
1 IU1) (the difference between routine and oligomycin-inhibited respiration).
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Routine respiration (1,545±90 pmol O2 s
1 IU1), as well as
maximal state III (after mitochondrial uncoupler FCCP
(carbonyl cyanide p-trifluoromethoxyphenylhydrazone))
(4,728±249 pmol O2 s
1 IU1) respiration rates were sig-
nificantly higher in sample A, followed by B (P¼0.02 for
routine respiration) and C (P¼ 0.03 for routine respiration;
P¼0.05 for maximal respiration; Table 2). Similarly, the rate
of respiration coupled with OXPHOS (R-j4o) (Table 2) and the
number of cells with high Dcm (Supplementary Figure S1
online, panel B) were higher in sample A, again followed by
B and C. When the relative level of intracellular ROS was
analyzed by dihydroethidium (DHE) staining, ROS levels
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Figure 1. Mitochondrial parameters in human skin fibroblasts.
(a) Mitochondrial mass content was quantified by the determination of citrate
synthase (CS) activity in 106 cells in three samples per age group (20, 60, and
90 years). Data represent the means±SE for three independent experiments.
(b) The electric potential of the inner mitochondrial membrane was measured
in situ using flow cytometry in intact cells stained with the JC-1 fluorescent
probe. JC-1 fluorescence was measured in three samples per age group (20,
60, and 90 years). The percentage of cells with high mitochondrial membrane
potential (Dcm) is displayed. Mitochondrial uncoupler, carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCCP; 5 mM), was used as a positive
control. Data represent the means±SE for three independent experiments.
(c) The level of the intracellular reactive oxygen species (ROS) was measured
in situ using flow cytometry in cells stained with the dihydroethidium (DHE)
fluorescent probe. Data (mean DHE fluorescence of 104 cells±SE) were
obtained from three independent experiments. Mitochondrial complex I
inhibitor rotenone (1 mM) was used as a positive control.
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Figure 2. Age-dependent changes in proteasome activity in human
fibroblasts. (a) Human foreskin fibroblasts (HFF-2) were infected with lentiviral
vectors carrying a green fluorescent protein (GFP)–degron gene or a
GFP–degronFS (frameshift) construct, as indicated. At 9 days after infection, cells
were visualized by fluorescence microscopy. (b) HFF-2 were treated as in a and
analyzed for GFP fluorescence using FACScan. Where indicated, cells were also
treated with proteasome inhibitor N-acetyl-L-leucyl-L-leucyl-L-norleucinal (LLnL).
Uninfected cells were used as a control. Experiments were performed in
triplicates; shown is the result of one representative experiment. (c) Skin
fibroblasts from nine different donors in the indicated age groups were minimally
expanded and infected with lentiviral constructs coding for GFP–degron. At 9
days after infection, the cells were analyzed by flow cytometry. Data were
obtained on three samples per age group in duplicates (± SE).
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were lowest in sample A (2.15±0.03), followed by B
(2.55±0.06, P¼0.02) and C (3.30±0.03, P¼ 0.001 with
respect to A) (Supplementary Figure S1 online, panel C). The
data indicate that the different numbers of elapsed in vitro
PDLs between strains A, B, and C strongly influenced mito-
chondrial function, consistent with the observation that
mitochondrial function declines during in vitro passaging in
human fibroblasts (Hutter et al., 2004; Passos et al., 2007).
Apparently, the effect of in vitro subculturing was dominant
over any effects related to donor age.
The same fibroblast cultures were infected with lentiviral
vectors, which code for the GFP–degron construct and the
GFP–degronFS construct, respectively; subsequently cells
were analyzed for GFP fluorescence. Significant differences
between the individual isolates were observed. The percen-
tage of cells where GFP–degron yielded a positive signal
(indicative of lowered proteasome activity) was 18% for
strain C (29 years/18 PDL), 16% for sample B (36 years/14
PDL), and lowest, namely 4.4% for sample A (46 years/9
PDL) (Supplementary Figure S1 online, panel D). When
cells were infected with lentiviral vectors coding for GFP–
degronFS fusion proteins (Supplementary Figure S1 online,
panel D), a similar percentage of GFP-positive cells was
observed in all cases. These findings indicate that proteasome
activity was highest in sample A, followed by samples B and
C, thereby paralleling our findings with mitochondrial
activity. In concordance with the mitochondrial measure-
ments, the influence of in vitro passaging was apparently
dominant over potential contributions of donor age.
Interdependence of mitochondrial function and proteasome
activity
The observation that mitochondrial and proteasome activities
are coregulated in the dermal fibroblast cultures analyzed in
this communication raises the question of a possible
interdependence of mitochondrial function and proteasome
activity. To address this question, mitochondrial activity
was monitored by high-resolution respirometry in human
dermal fibroblasts (HFF-2) in which the proteasome was
pharmacologically inhibited. When proteasome activity was
inhibited by LLnL, we observed a significant and dose-
dependent decrease of mitochondrial respiration rate at
3 hours after addition of LLnL (Po0.005; Figure 3a), and
addition of LLnL also significantly (Po0.005) reduced the
part of respiratory activity coupled with adenosine-5’-tripho-
sphate (ATP) production (Figure 3b). To determine if
proteasome inhibition affects the maximal respiratory capa-
city of the cells, oxygen consumption was also measured in
the presence of the uncoupling agent FCCP. This experiment
confirmed that proteasome inhibition reduced the maximal
respiratory capacity, whereas the coupling state of the
mitochondria was not affected by inhibition of the protea-
some (Figure 3c).
Additional experiments were performed to address poten-
tial mechanisms by which proteasome inhibition may affect
mitochondrial function. We addressed the possibility that
inhibition of the proteasome may affect quality control of
nuclearly encoded subunits of the mitochondrial respiratory
chain, which may result in the accumulation of unprocessed
proteins. Using antibodies to subunits of complexes IV and V
in western blot experiments, we found that proteasome
inhibition did not lead to any detectable accumulation
of unprocessed proteins (Supplementary Figure S2 online).
As expected, proteasome inhibition led to a significant
upregulation of ATP concentration (Supplementary Figure
S3 online).
Conversely, inhibition of mitochondrial respiratory activity
with rotenone led to a significant (Po0.005) downregulation
of proteasome activity (increased GFP fluorescence) in
GFP–degron-expressing HFF-2 cells (Figure 3d); GFP fluores-
cence was not affected by rotenone treatment of GFP–
degronFS-expressing HFF-2 cells (data not shown). Additional
experiments were performed to address potential mechan-
isms by which inhibition of mitochondria may affect
proteasome function. Whereas ATP levels were not signifi-
cantly reduced in rotenone-treated fibroblasts (Supplemen-
tary Figure S3 online), we found a slight upregulation in the
concentration of protein carbonyls, determined by Oxyblot
technology (Supplementary Figure S4 online). We also
observed an increase in the level of free cytosolic calcium
ions in rotenone-treated cells (data not shown), suggesting
that intracellular calcium homeostasis is significantly affected
after mitochondrial inhibition.
Taken together, the data suggest that pharmacological
inhibition of the proteasome induces mitochondrial dysfunc-
tion, and that inhibition of mitochondrial activity contributes
to the decreased proteasome activity in HFF-2 cells,
suggesting that both pathways are tightly interconnected.
Table 2. Mitochondrial respiration in human skin
fibroblasts derived from three subsequent biopsies
Mean (SE)1
A (46 years;
9 PDL)
B (36 years;
14 PDL)
C (29 years;
18 PDL)
Respiration/CS
Routine 1,545 (90) 1,226 (43)* 1,137 (139)*
Oligomycin 309 (43) 131 (70) 233 (46)
Uncoupled 4,728 (249) 4,161 (192) 3,812 (112)*
Rotenone 100 (43) 76 (31) 75 (44)
Antimycin A 43 (73) 52 (37) 49 (49)
(R-j4o)/CS
2 1,237 (99) 1,095 (32) 904 (93)
Abbreviations: CS, citrate synthase; PDL, population doubling level;
R, routine respiration.
1Skin fibroblasts obtained from one donor at the indicated age were obtained
from Corriell Institute at the indicated PDL number; samples are referred to as
samples A, B, and C, as before. After thawing, cells were minimally
expanded and analyzed. Respiration was measured by high-resolution
respirometry. Values were normalized by mitochondrial mass marker CS
activity expressed in international units (IU) (pmol of O2 s
1 IU1). Data
represent the means±SE for three independent experiments.
2(R-j4o)/CS is the rate of respiration coupled with ATP production (pmol of
O2 s
1 IU1) (the difference between routine and oligomycin-inhibited
respiration).
*Po0.05, with respect to sample A.
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DISCUSSION
In this study, we report that Dcm is significantly reduced with
donor age, when skin biopsies from young, middle-aged,
and old donors were compared. Reduced mitochondrial
functionality was accompanied by an increase in ROS level.
We also observed a decrease of proteasome activity with
donor age, determined by a new assay based on destabilized
GFP protein. We found that mitochondrial function and
proteasome activity are coregulated in samples from young,
middle-aged, and old donors reflecting human skin aging,
and our finding that inhibitors of mitochondria and the
proteasome affect the activity of both systems in parallel
suggests that they are functionally linked.
Functional decline of mitochondria and proteasomes
in aging skin
Several previous studies have addressed the role of mito-
chondria in human aging, in particular in dermal fibroblasts.
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Figure 3. Functional interdependence of mitochondrial and proteasome activity. (a) Human foreskin fibroblasts (HFF-2) were incubated for 3 hours with
N-acetyl-L-leucyl-L-leucyl-L-norleucinal (LLnL) as indicated, and respiration rate was determined. The experimental regime started with routine respiration,
followed by addition of oligomycin (1 mg ml1), and stepwise titration of carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP; 2.5–4 mM). Finally,
respiration was inhibited by sequential addition of rotenone at 0.5 mM and antimycin A (Ant.A) at 2.5 mM. Data represent the means±SE for four independent
experiments. (b) HFF-2 were incubated for 3 hours with LLnL, as indicated, and subjected to high-resolution respirometry as in a. The rate of oxygen
consumption coupled with mitochondrial adenosine-5’-triphosphate (ATP) production was calculated as the difference between routine respiration (R) and
respiration inhibited by oligomycin (j4o). (c) HFF-2 cells were treated with 100 mM LLnL for 3 hours and the rate of routine (R) and maximal uncoupled respiration
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(UCR) was calculated as a ratio of maximal respiration and the rate of routine respiration (j3u/R). Left panel shows representative experiment; right panel represents
data calculated out of three independent experiments. NS, not significant. (d) HFF-2 were infected with lentiviral constructs coding for GFP–degron, or left uninfected
as indicated. Cells were incubated with 0.5mM rotenone for 30minutes, and proteasome activity was analyzed by FACS as in Figure 2.
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It was concluded from in vitro senescence studies that
mitochondrial dysfunction is responsible for senescence-
associated cell degeneration (Hutter et al., 2004; Passos et al.,
2007), and pharmacological inhibition of mitochondrial
activity was shown to induce premature senescence in
human dermal fibroblasts (Stockl et al., 2006, 2007).
Concerning mitochondrial function in aging in vivo, rela-
tively little data are available. In one study, nearly 100
fibroblast strains from different sources were analyzed for
mitochondrial function, using mitochondrial protein synth-
esis, and oxygen consumption assays (Greco et al., 2003).
It was concluded that OXPHOS efficiency is reduced
with increasing donor age. However, the interpretation of
the results obtained in this study is complicated by the
fact that (1) biopsies were obtained from various different
locations, (2) cells were analyzed at undefined passage
levels, and (3) the respiratory parameters were not normal-
ized to mitochondrial mass.
As is evident from our studies, there are significant
differences in cellular mitochondrial mass content between
samples from donors of different ages (Figure 1a) and the
amount of in vitro passaging of cells is a critical parameter, as
it influences mitochondrial function to apparently higher
extent than does donor age. Interestingly, the results of our
studies suggest that although the Dcm is reduced in elderly
donors, the mitochondrial respiratory activity is not signifi-
cantly related to chronological age. This finding may be
explained by compensatory mechanisms in cells with
reduced Dcm. More work is required to clarify this question.
Using a previously unreported system to determine
proteasome activity in living cells based on a destabilized
version of GFP, we found that proteasome activity is
significantly reduced in skin fibroblasts from middle-aged
subjects compared with young subjects. Interestingly, there
was no further decrease of proteasome activity in the old age
group, and we noted a drastic increase in interindividual
variation within this group. These data on proteasome activity
are consistent with the findings of Hwang et al. (2007), who
reported decreased proteasome activity in extracts from
fibroblasts of middle age groups, but no further decline in
the very old age groups. This bimodal distribution probably
reflects the fact that nonagenarians underwent some selection
for highly robust genotypes/phenotypes, thereby putting
a bias on the selection of the population, in contrast to the
young and middle-aged groups, representing the general
population.
An interesting aspect of this study is the comparison of
biopsies obtained from populations at various ages, and
biopsies obtained from a single individual taken at different
ages. These latter biopsies were not derived in our laboratory,
but were provided by the Coriell Institute (www.coriell.org),
which has a long tradition in biobanking. Although the
available fibroblast strains from the same subject were not
optimal, as they could only be obtained at different degrees of
subculturing, the analysis of these samples nevertheless
revealed that there is a huge influence of in vitro passaging,
which significantly outweighs the influence of donor age.
This is true for both mitochondrial and proteasome function.
Another difference to the results obtained with random
populations lies in the fact that changes in mitochondrial
function were well reflected in respiratory activity in the
Coriell samples. This finding suggests that the huge differ-
ences in respiratory activity obtained for the population
samples may be related to genetic heterogeneity in the
human population, most of which is eliminated, when
biopsies from one and the same person are analyzed.
Functional interplay between proteasome and mitochondria
In the biopsies obtained from Corriell Institute, we found a
complete coregulation of mitochondrial and proteasome
function, which were both primarily determined by the
extent of in vitro passaging. These data suggest that in the
absence of genetic variation, there is a clearcut interdepen-
dence of both activities. This conclusion could be confirmed
by an additional set of experiments, where we found that
inhibition of proteasome by LLnL led to a dose-dependent
reduction in both routine and maximal (after mitochondrial
uncoupling) respiration, and the rate of respiration coupled
with ATP production.
The observation that inhibition of mitochondria by
rotenone led to a decrease in proteasome function may be
explained by the fact that inhibition of mitochondrial complex
I by rotenone leads to increased ROS production (Fato et al.,
2009) that in turn increases the proportion of oxidized
proteins, which are known to inhibit proteasome function
(Breusing and Grune, 2008). Indeed, inhibition of mitochon-
drial activity increased the amount of protein carbonyls
(Supplementary Figure S4 online), suggesting that accumula-
tion of oxidized proteins in cells with impaired mitochondrial
function contributes to the inhibition of the proteasome.
Mitochondria are the major sources of ATP in many cell
types, whereas the proteasome is a major ATP-consuming
organelle in most cell types. Hence, it is conceivable that
the functional link between mitochondria and proteasomes,
as described in this study, may have to do with alterations
of intracellular ATP concentrations. Indeed, ATP levels
increased upon inhibition of the proteasome, suggesting that
metabolic control contributes to the downregulation of
mitochondrial activity in LLnL-treated cells. On the other
hand, inhibition of mitochondrial function by rotenone only
slightly reduced intracellular ATP levels, consistent with our
previous observation that in human diploid fibroblasts, ATP
production depends 490% on glycolytic ATP production
(Zwerschke et al. 2003). This result suggests that the loss of
proteosomal activity observed upon inhibition of the mito-
chondria is not because of ATP depletion. Accordingly,
proteasome activity could not be rescued by addition
of exogenous ATP to the cells (data not shown).
In view of results presented in this study, it is interesting to
note that both proteasomes and mitochondria were impli-
cated in extrinsic skin aging. Thus, mtDNA mutations can be
induced in skin cells in vitro and in normal human skin
in vivo by repetitive, sublethal UVA irradiation (Berneburg
et al., 2005). Moreover, UVA irradiation leads to inhibition of
the proteasome in human skin fibroblasts (Catalgol et al.,
2009, reviewed by Krutmann and Schroeder, 2009). A
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possible functional interplay between mitochondria and
proteasome was noted in three earlier reports. On one hand,
proteasome inhibition reduced dramatically the activities of
mitochondrial complex I and II in an established neural cell
line (Sullivan et al., 2004). On the other hand, it was shown
that inhibition of the proteasome in human fetal lung
fibroblasts (WI-38) induced the dysfunction of respiratory
complexes I, II, and III in isolated mitochondria and increased
ROS levels in intact cells (Torres and Perez, 2008). In
addition, it was shown recently that rotenone inhibits
proteasome in an established neuronal cell line, and that
this effect can be attenuated by antioxidants (Chou et al.,
2010). However, functional links between both organelles in
skin aging were not addressed before. To be able to address
this question properly in this study, we had to apply a
set of unique experimental model systems. For example, all
biopsies collected from the Leiden-based population studies
were passaged to the very same extent under identical
conditions. Furthermore, a detailed analysis of mitochondria
and proteasome function in consecutive biopsies from the
very same donor, made possible by using staged biopsies
from Coriell Institute, has not been described before. The
interdependence of mitochondrial and proteasome function
in the context of human skin aging, as shown in this
communication, was not reported before.
MATERIALS AND METHODS
Chemicals
All chemicals were purchased from Sigma, unless indicated otherwise.
Subjects
Fibroblasts were obtained from subjects of the Leiden 85-plus Study
(Bootsma-van der Wiel et al., 2002) and the Leiden Longevity Study.
A biobank was established from fibroblasts cultivated from skin
biopsies from 68 of the surviving 90-year-old participants and from
27 young subjects (23–29 years old). Within the framework of the
Leiden Longevity Study (Schoenmaker et al., 2006), skin biopsies
were obtained from middle-aged offspring enriched for familiar
longevity and their partners (mean age¼ 60±8 years). Within this
study, fibroblast strains isolated from partners, representing the
general population, were used. The research has been performed in
accordance with the Declaration of Helsinki Principles (2000) of the
World Medical Association and has been approved by the Ethics
Committee of Leiden University Medical Center. Informed consent
was obtained from all subjects.
All fibroblast strains were isolated from skin biopsies of the upper
medial arm and cultured under highly standardized conditions.
Experiments were set up from randomly selected frozen fibroblast
stocks at passage seven (Maier et al., 2007; Dekker et al., 2009).
Experiments were performed using fibroblast strains from three
subjects per age group (young, middle-aged, and old subjects).
Cell culture
HFF-2 pooled from four newborn were purchased from the ATCC
(Manassas, VA) at a passage number of six. Human fibroblasts were
maintained in DMEM (Sigma) as described (Hutter et al., 2004). Skin
fibroblasts taken from one healthy donor of various ages were purchased
from the Coriell Institute (Camden, NJ; http://www.coriell.org).
High-resolution respirometry
Cells were harvested, spun at 155 g for 5 minutes, and finally
resuspended in DMEM. Cell number was determined using CASY 1
Cell Counter and Analyser System (Scha¨rfe System, Reutlingen,
Germany). Approximately 1 106 intact cells were resuspended in
3 ml of DMEM (Gibco, Vienna, Austria) and applied for high-
resolution respirometry using Oxygraph-2k (Oroboros Instruments,
Innsbruck, Austria).
The experimental regime started with routine respiration (defined
as respiration in culture medium without any additional substrates or
effectors). After observing steady-state respiratory flux, the ATP
synthase inhibitor oligomycin (1mg ml1) was added, followed by
uncoupling of OXPHOS by stepwise titration of FCCP up to optimum
concentrations in the range of 2.5–4mM. Finally, respiration was
inhibited by complex I and complex III inhibitors rotenone (0.5 mM)
and antimycin A (2.5 mM), respectively. DatLab software (Oroboros
Instruments, Innsbruck, Austria) was used for data acquisition and
analysis. The respirometry data were normalized to the mitochon-
drial mass marker enzyme citrate synthase activity as described
(Kuznetsov et al., 2002). Briefly, two portions of 300 ml of the sample
were taken from the cell suspension stirred in the Oxygraph chamber
before the chamber was closed for recording respiration. Samples
were frozen in liquid nitrogen and stored at 80 1C. Total cell lysate
(100ml) was added to 900ml of medium containing 0.1 mM 5,5-
dithio-bis-(2-nitrobenzoic) acid (DTNB), 0.5 mM oxaloacetate, 50 mM
EDTA, 0.31 mM acetyl-CoA, 5 mM triethanolamine hydrochloride,
and 0.1 M Tris/HCl (pH 8.1). The activity of citrate synthase was
measured spectrophotometrically at 412 nm and 30 1C.
Determination of Dwm
The electric potential of the inner mitochondrial membrane was
measured in situ using flow cytometry in cells stained with the JC-1
(Molecular Probes, Leiden, The Netherlands) fluorescent probe
(Cossarizza et al., 1993). 2 105 cells were suspended in 2 ml of the
culture medium supplemented with 0.5mg ml1 of JC-1. The cells
were incubated for 30 minutes at 37 1C, washed twice with
phosphate-buffered saline (PBS), and resuspended in PBS containing
1 mM pyruvate and 5 mM glucose. JC-1 fluorescence was measured
using flow cytometry (FACS Canto II, Becton Dickinson, Heidelberg,
Germany) in 104 cells. In healthy cells, JC-1 enters the negatively
charged mitochondria where it aggregates and fluoresces red. When
mitochondrial potential drops, JC-1 exists as monomers in cytoplasm
and fluoresces green. It allows to define two populations of cells,
with high Dcm (high red, low green fluorescence) and low Dcm (low
red, high green fluorescence). Preincubation of the cells with
mitochondrial uncoupler FCCP allowed defining the cell population
with lowered Dcm (mean value of green channel fluorescence above
104 (arbitrary units) and mean value of red channel fluorescence
below 104). All cells with lower green and higher red fluorescence
were counted as the cells with high Dcm (percentage of population).
Assessment of ROS
The level of the intracellular ROS was measured in situ using flow
cytometry in cells stained with the DHE fluorescent probe
(Molecular Probes). The cells (2 105) were suspended in 1 ml of
the culture medium containing 20 mM DHE. The cells were incubated
for 30 minutes at 37 1C, washed twice with PBS, and resuspended in
PBS. DHE fluorescence was measured using a flow cytometer (FACS
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Canto II, Becton Dickinson). The level of ROS level was estimated as
a mean value of DHE fluorescence in 104 cells. Mitochondrial
complex I inhibitor rotenone (1mM) was added along with DHE as a
positive control.
Determination of proteasome activity
Complementary DNA constructs coding for the GFP–degron fusion
protein (unstable) and the variant carrying a frameshift mutation
(stable) were inserted in lentiviral expression vectors, using the
pLenti6/V5-DEST Gateway system (Invitrogen, Vienna, Austria). For
packaging of the lentivirus in 293FT cells (Invitrogen), we used
psPAX2 and the envelope encoding plasmid pMD2.G from
Addgene, Cambridge, MA. HEK 293FT cells were cultivated in
T75 flasks to 90% confluence and transfected with a mixture of 3 mg
pLenti6/V5, 7.5 mg psPAX2, and 2.5 mg pMD2.G by Lipofectamine
(Invitrogen). Supernatant was harvested 72 hours after transfection.
The titer of lentiviral particles was determined in U2OS cells
(Salmon and Trono, 2006). For transduction of HFF-2, a multiplicity
of infection of two was used together with 8mg ml1 hexadimethrine
bromide as transduction enhancer. The percentage of GFP-positive
(FITC) cells was measured using flow cytometry (FACS Canto II,
Becton Dickinson) in GFP–degron- and GFP–degronFS-transduced
cells. Approximately 1 105 cells were used for measurement.
Statistics
All analyses were performed with the DatLab/BD FACSDiva software
(Becton Dickinson). Three subjects per group were used. Results of the
experiments were averaged. Differences in cellular characteristics
between the group of young, middle-aged, and old subjects (n¼ three
each) were compared using Student’s t-test and were represented as
mean±SE. As experiments were performed in batches of three
fibroblast strains simultaneously (one strain of each age group),
differences were also compared using linear mixed-effect models to
account for repeat experiments and batch effects.
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